Fragrance raw materials and essential oils can reduce prostaglandin E 2 formation in keratinocytes and reconstituted human epidermis

International Journal of Cosmetic Science

Volumn 29, Issue 5, 2007, Pages 369-376

  Natsch, Andreas ^a   Wasescha, Michael ^a  

^a GIVAUDAN SCHWEIZ AG   (Switzerland)

Author keywords

Anti irritant activity; Essential oils; Fragrance; Keratinocytes; Prostaglandins; Reconstituted epidermis

Indexed keywords

ANTIPERSPIRANT AGENT; ESSENTIAL OIL; FRAGRANCE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN CELL; HYDROGEL; KERATINOCYTE; NONHUMAN; SKIN IRRITATION; SWINE; THROMBOCYTE;

EID: 34648828559     PISSN: 01425463     EISSN: 14682494     Source Type: Journal    
DOI: 10.1111/j.1468-2494.2007.00392.x     Document Type: Article

References (15)

1. Nakatsu, T., Lupo A.T., Jr., Chinn, J.W., Jr. Kang, R.K.L. Biological activity of essential oils and their constituents. Stud. Nat. Prod. Chem. (Bioactive Nat. Prod. B) 21, 571 631 (2000).
2. Pongprayoon, U., Soontornsaratune, P., Jarikasem, S., Sematong, T., Wasuwat, S. Claeson, P. Topical antiinflammatory activity of the major lipophilic constituents of the rhizome of Zingiber cassumunar. Part 1. The essential oil. Phytomedicine 3, 319 322 (1997).
3. Dewhirst, F.E. Structure-activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds. Prostaglandins 20, 209 222 (1980).
4. Tipton, D.A., Lyle, B., Babich, H. Dabbous, M.K. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol. In Vitro 17, 301 310 (2003).
5. Peana, A.T., Marzocco, S., Popolo, A. Pinto, P. (-)-Linalool inhibits in vitro NO formation: probable involvement in the antinociceptive activity of this monoterpene compound. Life Sci. 78, 719 723 (2006).
6. Safford, R.J., Basketter, D.A., Allenby, C.F. Goodwin, B.F.J. Immediate contact reactions to chemicals in the fragrance mix and a study of the quenching action of eugenol. Br. J. Dermatol. 123, 595 606 (1990).
7. Gaffar, A., Scherl, D., Afflitto, J. Coleman, E.J. The effect of triclosan on mediators of gingival inflammation. J. Clin. Periodontol. 22, 480 484 (1995).
8. Barkvoll, P. Roella, G. Triclosan protects the skin against dermatitis caused by sodium lauryl sulfate exposure. J. Clin. Periodontol. 21, 717 719 (1994).
9. Ward, R.K., Hubbard, A.W., Sulley, H., Garle, M.J. Clothier, R.H. Human keratinocyte cultures in an in vitro approach for the assessment of surfactant-induced irritation. Toxicol. In Vitro 12, 163 173 (1998).
10. 2 release in human skin keratinocyte cultures. Toxicol. In Vitro 11, 627 631 (1997).
11. Muller-Decker, K., Heinzelmann, T., Furstenberger, G., Kecskes, A., Lehmann, W.-D. Marks, F. Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. Toxicol. Appl. Pharmacol. 153, 59 67 (1998).
12. Dannhardt, G., Flemmer, L., Hartmann, R.W., Kleber, A. Schulze, E. Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibition. Arch. Pharm. (Weinheim) 331, 359 364 (1998).
13. Natsch, A Wasescha, M. Fragrance composition with the properties to reduce or suppress formation of skin irritation. International patent application. WO 2007030961, Givaudau S.A., Switzerland (2007).
14. Giersch, W.K. Fragrance compositions comprising arylalkyl aldehydes. Firmenich S.A., Switzerland (1999), CH 689372, Firmenich S.A., Switzerland (1999).
15. Wagner, H., Wierer, M. Bauer, R. In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds. Planta Med. 3, 184 187 (1986).